Literature DB >> 25232529

Psoriatic arthritis: Epidemiology, diagnosis, and treatment.

Jung-Tai Liu1, Horng-Ming Yeh1, Shyun-Yeu Liu1, Kow-Tong Chen1.   

Abstract

Our understanding of psoriatic arthritis has evolved as new knowledge of the disease has emerged. However, the exact prevalence of psoriatic arthritis is unknown, and its pathogenesis has not been fully elucidated. Genetic, environmental, and immunologic factors have all been implicated in disease development. Early diagnosis and treatment have become primary objectives in clinical rheumatology. Psoriatic arthritis not only causes functional impairment, but also increases mortality risk of patients. The advent of new therapeutic agents capable of arresting the progression of joint damage is expected. However, early psoriatic arthritis assessment remains limited. The objectives of this article are to outline the epidemiology, diagnosis, and treatment of psoriatic arthritis and to suggest a paradigm for identifying early psoriatic arthritis patients.

Entities:  

Keywords:  Arthritis; Psoriasis; Psoriatic arthritis; Spondyloarthritis

Year:  2014        PMID: 25232529      PMCID: PMC4133459          DOI: 10.5312/wjo.v5.i4.537

Source DB:  PubMed          Journal:  World J Orthop        ISSN: 2218-5836


  65 in total

1.  Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study.

Authors:  P Trontzas; A Andrianakos; S Miyakis; K Pantelidou; E Vafiadou; V Garantziotou; C Voudouris
Journal:  Clin Rheumatol       Date:  2005-04-29       Impact factor: 2.980

2.  The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics.

Authors:  Laura C Coates; William Tillett; David Chandler; Philip S Helliwell; Eleanor Korendowych; Stuart Kyle; Iain B McInnes; Susan Oliver; Anthony Ormerod; Catherine Smith; Deborah Symmons; Nicola Waldron; Neil J McHugh
Journal:  Rheumatology (Oxford)       Date:  2013-07-25       Impact factor: 7.580

Review 3.  Early psoriatic arthritis: facing the challenge.

Authors:  Deborah Palmer; Y El Miedany
Journal:  Br J Nurs       Date:  2013 Sep 12-25

4.  Prevalence of spondyloarthropathies in France: 2001.

Authors:  A Saraux; F Guillemin; P Guggenbuhl; C H Roux; P Fardellone; E Le Bihan; A Cantagrel; I Chary-Valckenaere; L Euller-Ziegler; R-M Flipo; R Juvin; J-M Behier; B Fautrel; C Masson; J Coste
Journal:  Ann Rheum Dis       Date:  2005-04-07       Impact factor: 19.103

5.  Prevalence of spondyloarthropathies and HLA-B27 in the native population of Chukotka, Russia.

Authors:  L Alexeeva; M Krylov; V Vturin; N Mylov; S Erdesz; L Benevolenskaya
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

6.  Axial psoriatic arthritis: update on a longterm prospective study.

Authors:  Vinod Chandran; Jessica Barrett; Catherine T Schentag; Vernon T Farewell; Dafna D Gladman
Journal:  J Rheumatol       Date:  2009-11-02       Impact factor: 4.666

7.  High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case-control study.

Authors:  Esperanza Naredo; Ingrid Möller; Eugenio de Miguel; Enrique Batlle-Gualda; Carlos Acebes; Elia Brito; Lucía Mayordomo; Carmen Moragues; Jacqueline Uson; Juan J de Agustín; Agustín Martínez; Eduardo Rejón; Ana Rodriguez; Esteban Daudén
Journal:  Rheumatology (Oxford)       Date:  2011-06-23       Impact factor: 7.580

8.  The role of dynamic contrast-enhanced MRI in the differential diagnosis of psoriatic and rheumatoid arthritis.

Authors:  Nina F Schwenzer; Ina Kötter; Jörg C Henes; Christina Schraml; Jan Fritz; Claus D Claussen; Marius Horger
Journal:  AJR Am J Roentgenol       Date:  2010-03       Impact factor: 3.959

9.  Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.

Authors:  L Williamson; N Dalbeth; J L Dockerty; B C Gee; R Weatherall; B P Wordsworth
Journal:  Rheumatology (Oxford)       Date:  2004-04-27       Impact factor: 7.580

10.  Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey.

Authors:  Elina Savolainen; Oili Kaipiainen-Seppänen; Liisa Kröger; Riitta Luosujärvi
Journal:  J Rheumatol       Date:  2003-11       Impact factor: 4.666

View more
  33 in total

Review 1.  Disease burden and treatment challenges of psoriatic arthritis in Africa and the Middle East.

Authors:  Mohamed Bedaiwi; Ibrahim A Al-Homood; Ayman El-Garf; Imad Uthman; Nancy Sunna; Reenad Nassier; Haytham Mohamed; Jamal Al Saleh
Journal:  Rheumatol Int       Date:  2019-05-27       Impact factor: 2.631

2.  Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis.

Authors:  Michael Peled; Marianne Strazza; Inbar Azoulay-Alfaguter; Gregg J Silverman; Jose U Scher; Adam Mor
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

3.  Psoriatic Arthritis Quality of Life questionnaire: translation, cultural adaptation and validation into Portuguese language.

Authors:  Anabela Barcelos; Catarina Ambrósio; J A Pereira da Silva; Stephen McKenna; Jeanette Wilburn; Pedro Lopes Ferreira
Journal:  Rheumatol Int       Date:  2017-10-30       Impact factor: 2.631

4.  Subjective Health Complaints in Individuals with Psoriasis and Psoriatic Arthritis: Associations with the Severity of the Skin Condition and Illness Perceptions - A Cross-Sectional Study.

Authors:  Emma Charlott Andersson Nordbø; Geir Aamodt; Camilla Martha Ihlebæk
Journal:  Int J Behav Med       Date:  2017-06

5.  Unmet needs in psoriatic arthritis patients receiving immunomodulatory therapy: results from a large multinational real-world study.

Authors:  Rieke Alten; P G Conaghan; V Strand; E Sullivan; S Blackburn; H Tian; K Gandhi; S M Jugl; A Deodhar
Journal:  Clin Rheumatol       Date:  2019-02-04       Impact factor: 2.980

6.  Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry.

Authors:  Leslie R Harrold; Bradley S Stolshek; Sabrina Rebello; David H Collier; Alex Mutebi; Sally W Wade; Wendi Malley; Jeffrey D Greenberg; Carol J Etzel
Journal:  Clin Rheumatol       Date:  2017-03-07       Impact factor: 2.980

7.  Mapping Quality of Life (EQ-5D) from DAPsA, Clinical DAPsA and HAQ in Psoriatic Arthritis.

Authors:  Tomas Mlcoch; Jan Tuzil; Liliana Sedova; Jiri Stolfa; Monika Urbanova; David Suchy; Andrea Smrzova; Jitka Jircikova; Tereza Hrnciarova; Karel Pavelka; Tomas Dolezal
Journal:  Patient       Date:  2018-06       Impact factor: 3.883

8.  Gastrointestinal comorbidities in patients with psoriatic arthritis.

Authors:  Ariel Zohar; Arnon Dov Cohen; Haim Bitterman; Ilan Feldhamer; Sari Greenberg-Dotan; Idit Lavi; Doron Comanesther; Erez Batat; Devy Zisman
Journal:  Clin Rheumatol       Date:  2016-08-17       Impact factor: 2.980

Review 9.  Pain Management in Painful Psoriasis and Psoriatic Arthropathy: Challenging and Intricately Intertwined Issues Involving Several Systems.

Authors:  Vijay Kodumudi; Kanishka Rajput
Journal:  Curr Pain Headache Rep       Date:  2021-04-06

10.  Plasma gelsolin levels in patients with psoriatic arthritis: a possible novel marker.

Authors:  Marwa M Esawy; Wafaa K Makram; Waleed Albalat; Marwa A Shabana
Journal:  Clin Rheumatol       Date:  2020-01-30       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.